临床肝胆病杂志
臨床肝膽病雜誌
림상간담병잡지
CHINESE JOURNAL OF CLINICAL HEPATOLOGY
2009年
3期
211-214
,共4页
王波%陈松劲%于亚威%杨志宏%斯淑英%俞蕾敏%吕宾
王波%陳鬆勁%于亞威%楊誌宏%斯淑英%俞蕾敏%呂賓
왕파%진송경%우아위%양지굉%사숙영%유뢰민%려빈
胎盘提取液%脂肪性肝病%瘦素%肿瘤坏死因子%白介素-6
胎盤提取液%脂肪性肝病%瘦素%腫瘤壞死因子%白介素-6
태반제취액%지방성간병%수소%종류배사인자%백개소-6
Placenta extracts%Fatty liver disease%Leptin%Tumor necrosis factor%IL-6
目的 探讨人胎盘提取液对高脂饮食性脂肪性肝病的治疗作用及其机理.方法 42只Wistar大鼠,雄性,分为正常对照组(n=8,予普通标准饲料)和模型组(n=34,予高脂饮食,建立大鼠脂肪肝模型)喂饲12周后,将模型组随机分为造模组(n=8)、人胎盘提取液高剂量组(n=9)、人胎盘提取液低剂量组(n=9)、易善复对照组(n=8).4周后取血和肝组织.肝组织HE染色观察病理学改变,用放免法检测各组大鼠血浆及肝组织中Leptin、TNF-α、IL-6的含量.结果 人胎盘提取液低剂量组和易善复组较造模组有好转,但无明显差异(P>0.05),人胎盘提取液高剂量组脂肪浸润状态较造模组有明显好转,且差异有统计学意义(P<0.05).造模组大鼠血浆中Leptin、TNF-α、IL-6的含量均高于正常对照组(P<0.05),人胎盘提取液高、低剂量组、易善复对照组较造模组明显降低(P<0.05);血浆及肝组织溶浆中IL-6,TNF-α及Leptin的含量之间均无显著相关性.结论 人胎盘提取液对Leptin、TNF-α、IL-6等细胞因子具有明显的抑制作用,对高脂饮食脂肪性肝病动物模型具有明显的治疗作用.
目的 探討人胎盤提取液對高脂飲食性脂肪性肝病的治療作用及其機理.方法 42隻Wistar大鼠,雄性,分為正常對照組(n=8,予普通標準飼料)和模型組(n=34,予高脂飲食,建立大鼠脂肪肝模型)餵飼12週後,將模型組隨機分為造模組(n=8)、人胎盤提取液高劑量組(n=9)、人胎盤提取液低劑量組(n=9)、易善複對照組(n=8).4週後取血和肝組織.肝組織HE染色觀察病理學改變,用放免法檢測各組大鼠血漿及肝組織中Leptin、TNF-α、IL-6的含量.結果 人胎盤提取液低劑量組和易善複組較造模組有好轉,但無明顯差異(P>0.05),人胎盤提取液高劑量組脂肪浸潤狀態較造模組有明顯好轉,且差異有統計學意義(P<0.05).造模組大鼠血漿中Leptin、TNF-α、IL-6的含量均高于正常對照組(P<0.05),人胎盤提取液高、低劑量組、易善複對照組較造模組明顯降低(P<0.05);血漿及肝組織溶漿中IL-6,TNF-α及Leptin的含量之間均無顯著相關性.結論 人胎盤提取液對Leptin、TNF-α、IL-6等細胞因子具有明顯的抑製作用,對高脂飲食脂肪性肝病動物模型具有明顯的治療作用.
목적 탐토인태반제취액대고지음식성지방성간병적치료작용급기궤리.방법 42지Wistar대서,웅성,분위정상대조조(n=8,여보통표준사료)화모형조(n=34,여고지음식,건립대서지방간모형)위사12주후,장모형조수궤분위조모조(n=8)、인태반제취액고제량조(n=9)、인태반제취액저제량조(n=9)、역선복대조조(n=8).4주후취혈화간조직.간조직HE염색관찰병이학개변,용방면법검측각조대서혈장급간조직중Leptin、TNF-α、IL-6적함량.결과 인태반제취액저제량조화역선복조교조모조유호전,단무명현차이(P>0.05),인태반제취액고제량조지방침윤상태교조모조유명현호전,차차이유통계학의의(P<0.05).조모조대서혈장중Leptin、TNF-α、IL-6적함량균고우정상대조조(P<0.05),인태반제취액고、저제량조、역선복대조조교조모조명현강저(P<0.05);혈장급간조직용장중IL-6,TNF-α급Leptin적함량지간균무현저상관성.결론 인태반제취액대Leptin、TNF-α、IL-6등세포인자구유명현적억제작용,대고지음식지방성간병동물모형구유명현적치료작용.
Objective To investigate the effects and mechanisms of human placenta extracts to rats with nonalcoholic fatty liver disease.Methods Forty-two male Wistar rats were randomly divided into two groups: blank control group (n=8, fed by ordinary standard diet) and fatty-liver group (n=34, the fatty-liver models were established by feeding with high-fatty diet by a term of 12-week).Then the fatty-liver models were randomly scarified for model group (n=8),human placenta high dose group (n=9), human placenta low dose group (n=9) and Essentiale group (n=8).By the end of 4th week, histological examinations of liver were carried out with HE staining; meanwhile, the serum and tissue levels of Leptin、TNF-α、IL-6 were detected with RIA.Results The fatty degeneration in livers with low dose human placenta extracts and Essentiale were slightly milder than that of the models(P>0.05).While high dose human placenta could obviously lessen the fatty degeneration (P<0.05).Compared with the blank control group,the serum and tissue levels of Leptin、TNF-αand IL -6 in the model group were all remarkably increased(P<0.05). And the human placenta and Essentiale could typical relevance between the contents of Leptin、TNF-α and IL -6 both in serum and liver tissue.Conclusion Human placenta extracts is effective in treating fatty liver disease induced by high-fatty diet.This may be due to its effects in lowering the levels of the cytokines such as Leptin、TNF-αand IL-6.